- Numerous M&A transactions involving Chinese assets, including sale of a leading Chinese Vitamin C producer, auction of a Chinese banking subsidiary by an international conglomerate, spin-offs by multinationals of Chinese divisions and purchase of automotive financial leasing company.
- Numerous joint ventures between US tech companies and Chinese State-owned enterprises involving satellites, networking hardware, and telephony
- Restructurings of distressed companies, including China-focused companies with failed variable interest entities
- Negotiating the form contract used for import of all Hollywood revenue-sharing films into China
- Extensive work with private equity and venture capital funds on investments, dispositions and restructurings in China, including investment and subsequent restructuring of a leading Chinese coal bed methane company, investment in the largest out-of-home advertising company and investment in a leading Chinese company operating for-profit universities
- Structuring and negotiating RMB-denominated investment by Chinese domestic funds into offshore companies
- Representing numerous companies to negotiate equity, mezzanine and debt financings in China
- Numerous real estate transactions in China, including financings, long-term development partnerships for greenfield projects, and the acquisition and disposal of commercial and residential buildings by international financial institutions in China
- Numerous transactions involving overseas investment by Chinese companies, including sale of US analog chip company to consortium of Chinese buyers and financing of Chinese iron sands project in Indonesia
- Formation of small loan companies and other alternative investment structures for investing in distressed assets in China and taking collateral interests
- Market entry strategy, licensing arrangements and financings for film & television, gaming and Internet companies in China, including formation of joint ventures for distribution, production and exhibition of film and television properties and negotiating licensing arrangements for gaming properties
- Inversions and financings of numerous Chinese domestic companies in preparation for offshore listing
- Market entry strategy, financings and joint ventures for new energy companies expanding to China
- Market entry strategy and investment by life sciences funds into Chinese drug discovery and medical device opportunities, including numerous financings of drug discovery companies that have subsequently gone public
- Purchase of non-performing loan portfolios from Chinese banks
Languages
- Mandarin Chinese
Admissions
Bar Admissions
- New York
Education
- Columbia University, J.D., 1995: Harlan Fiske Stone Scholar
- Williams College, B.A., 1990: cum laude
Honors & Awards
- Recognized by Chambers Global in the Corporate/M&A category for the China region (2020-2026)
- Recognized by Chambers Asia-Pacific for Corporate/M&A: China-based (International Firms) (2008-2024) & Private Equity: Buyouts & Venture Capital Investment (International Firms) (2008-2023)
- Asia-Pacific Legal 500 (2021-2024): Hall of Fame lawyer for the categories of M&A and Private Equity in China
- Recognized by IFLR1000 as a "Leading Lawyer" (2022) and "Highly Regarded" (2018-2022) in Mergers & Acquisitions and Private Equity
- Asia-Pacific Legal 500 (2008-2020): Leading Individual lawyer for the categories of M&A and Private Equity in China
Related Practices
Related Industries
Related Regions